The biotechnology instruments market is growing due to personalized medicine, genomics, and molecular diagnostics.

State Key Laboratory of Pharmaceutical Biotechnology, HKU has the following research output in the current window (1 January 2025 - 31 December 2025) of the Nature Index. Click on Count to view a list ...

Manufacturing Agreement Advances Metformin Ophthalmology Platform Toward First-in-Human Clinical Study Palm Beach Gardens, FL, April 15, 2026 (GLOBE NEWSWIRE) -- Curative Biotechnology, Inc. (OTC: CUB ...

Biovelocita II attracts robust support from leading pharmaceutical companies, including Amgen, Bristol Myers Squibb, and Pfizer Ventures The fund has already screened over 300 projects and made ...

Dr. Wang Xin, Global Partner and President of Sullivan Greater China, together with Professor Yu Wang, Expert Advisor to the Judging Committee and Chairman of Chinese Foundation for Hepatitis ...

Synthekine Inc., an engineered cytokine therapeutics company, today announced the appointment of John A. Orwin as Chair of its Board of Directors. Mr. Orwin succeeds Srinivas Akkaraju, M.D., Ph.D., ...

Article ‘Count’ and ‘Share’ for State Key Laboratory of Pharmaceutical Biotechnology, HKU based on listed parameters only. The articles listed below published by authors from State Key Laboratory of ...

The evolving regulatory landscape and intensified focus on supplier qualifications present opportunities to enhance compliance and quality management. This course offers strategies for navigating ...

The main market opportunities lie in advancing protein engineering to develop innovative protein-based therapeutics, capitalizing on the pharmaceutical sector's demand for enhanced enzymes. This field ...

First commercial agreement with a top 5 global pharmaceutical company anchors a growing pipeline of enterprise discussions; runway secured into late 2027 ...